Drug Discovery

astars-genome-institute-of-singapore-gis-and-oxford-biodynamics-obd-will-use-episwitch-platform-to-differentiate-epigenetic-footprint-of-various-stem-cells-from-their-cell-lines

Prism to start PRI-724 trials to treat fibrosis

  • Japan
  • |
  • News

Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.... Read more

apotex-recalls-15-lots-of-piperacillin-and-tazobactam-for-injection-on-behalf-of-hospira

VM202 trial completes patient administration


  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients for... Read more

eisai-quintiles-joint-program-evaluating-effects-of-lenvatinib-vegf-receptor-tyrosine-kinase-inhibitor-and-multi-kinase-inhibitor-on-melanoma-shows-positive-results

Eisai, Quintiles cancer drug program shows +ve results...


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Eisai has revealed therapeutic effects of lenvatinib (generic name- VEGF receptor tyrosine kinase inhibitor and... Read more

hope-for-rheumatoid-arthritis-and-inflammatory-bowel-disease-patients-glenmark-develops-anti-ox40-monoclonal-antibody-gbr-830

Glenmark develops first-of-its-kind antibody

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical development anti-OX40... Read more

good-news-for-patients-suffering-from-pain-raqualia-pharma-and-interprotein-enter-into-collaborative-research-agreement

RaQualia, Interprotein to research on pain drug

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus on drug discovery... Read more

cytomegalovirus-treatments-to-improve

Cytomegalovirus treatments to improve

  • Europe
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generally asymptomatic in... Read more

chugai-application-japan

Chugai seeks nod for breast cancer drug in Japan

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labor and Welfare (MHLW)... Read more

scinopharm-foresee-joint-venture

ScinoPharm, Foresee form joint venture

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form a joint venture.... Read more

phylogica-janssen-collaboration

Phylogica extends collaboration with Janssen Biotech

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen Biotech and its affiliates... Read more

good-news-for-rheumatoid-arthritis-ra-patients-bone-medical-reveals-positive-findings-from-a-proof-of-concept-study-of-mozaic-peptide-discovery-technology-based-drug-candidate-bn006

Bone Medical reveals results of arthritis study

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for musculoskeletal diseases,... Read more

orexo-grants-astrazeneca-rights-to-conduct-trials-in-its-ox-cli-respiratory-program

AstraZeneca, Orexo to do respiratory drug trials

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Orexo entered into an agreement with AstraZeneca regarding preclinical program OX-CLI for a potential novel treatment of respiratory... Read more

good-news-for-chronic-iron-overload-patients-us-fda-approved-exjade-deferasirox

Exjade gets FDA nod for iron overload treatment

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years of age and older... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X